Cryomass Technologies Stock Debt To Equity
| CRYM Stock | USD 0.02 0.0003 1.89% |
Cryomass Technologies fundamentals help investors to digest information that contributes to Cryomass Technologies' financial success or failures. It also enables traders to predict the movement of Cryomass OTC Stock. The fundamental analysis module provides a way to measure Cryomass Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cryomass Technologies otc stock.
Cryomass |
Cryomass Technologies OTC Stock Debt To Equity Analysis
Cryomass Technologies' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Cryomass Technologies Debt To Equity | 0.02 % |
Most of Cryomass Technologies' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cryomass Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Cryomass Technologies has a Debt To Equity of 0.022%. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 99.95% higher than that of the company.
Cryomass Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cryomass Technologies' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cryomass Technologies could also be used in its relative valuation, which is a method of valuing Cryomass Technologies by comparing valuation metrics of similar companies.Cryomass Technologies is currently under evaluation in debt to equity category among its peers.
Cryomass Fundamentals
| Return On Equity | -1.16 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 42.41 M | |||
| Shares Outstanding | 202.53 M | |||
| Shares Owned By Insiders | 25.92 % | |||
| Price To Book | 4.44 X | |||
| Gross Profit | 37.18 K | |||
| EBITDA | (7.9 M) | |||
| Net Income | (12.86 M) | |||
| Cash And Equivalents | 2.19 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 177.08 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 2.07 X | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | (5.6 M) | |||
| Earnings Per Share | (0.08) X | |||
| Beta | 5.22 | |||
| Market Capitalization | 35.44 M | |||
| Total Asset | 15.58 M | |||
| Net Asset | 15.58 M |
About Cryomass Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cryomass Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cryomass Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cryomass Technologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.